Skip to content

Iodoxamic acid

VARIOUS

Also known as: iodoxamate, iodoxamate meglumine, iodoxamic acid meglumine salt

FDA approvedATC V08AC01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Iodoxamic acid is a drug catalogued in DrugCentral. It was first approved by the FDA in 1981.

  • ATC code: V08AC01 (Watersoluble, hepatotropic X-ray contrast media).
  • Molecular formula: C26H26I6N2O10; molecular weight 1287.92 g/mol.

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1981-08-14FDA—BRACCO

ATC classification

ATC codeTherapeutic hierarchy
V08AC01VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, hepatotropic X-ray contrast media

Chemical structure

Molecular formulaC26H26I6N2O10
Molecular weight1287.92 g/mol
CAS number51764-33-1
InChIKeyWWVAPFRKZMUPHZ-UHFFFAOYSA-N
PubChem CID35740
OC(=O)C1=C(I)C=C(I)C(NC(=O)CCOCCOCCOCCOCCC(=O)NC2=C(I)C(C(O)=O)=C(I)C=C2I)=C1I

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

When was Iodoxamic acid first approved?

Iodoxamic acid was first approved by the FDA in 1981.

What is the chemical formula of Iodoxamic acid?

Iodoxamic acid has the molecular formula C26H26I6N2O10 and a molecular weight of 1287.92 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1981-08-14
AgencyFDA
Targets0
Indications0
FormulaC26H26I6N2O10
DrugCentral ID3966
Interactive profile